Nuclear Radiology: Page 55

CT perfusion useful for evaluating small esophageal tumors
By Rabia Mughal
CT perfusion can be used to evaluate esophageal cancers with small tumor diameters that are not amenable to assessment with PET/CT, according to a new study by Turkish researchers presented at ECR 2014 earlier this month.
March 20, 2014
2014 03 20 10 46 22 142 2014 03 21 C Tperfusion Kantarci Thumb
IBA divests PharmaLogic PET Services
By AuntMinnieEurope.com staff writers
Ion Beam Applications (IBA) has sold the assets of its PharmaLogic PET Services of Montreal subsidiary to a private equity firm.
March 16, 2014
Global nuclear medicine market poised for growth
By AuntMinnieEurope.com staff writers
The global nuclear medicine market will reach $24 billion by 2030 (18 billion euros), with an annual average increase of 11%, according to a new market research report by MEDraysintell.
March 13, 2014
MILabs wins Dutch contract
By AuntMinnieEurope.com staff writers
MILabs has won an installation of its MILabs U-SPECT+/CT system at a Dutch cancer institute.
March 10, 2014
Study finds PET/CT can help diagnose CUP syndrome
By Erik L. Ridley
VIENNA - FDG-PET/CT can identify a possible primary tumor in patients with carcinoma with unknown primary tumor (CUP) syndrome at a rate comparable to that found in autopsy studies, German researchers reported on Monday at ECR 2014.
March 9, 2014
2014 03 06 11 26 36 325 200x200 Ecr 2014
Controversy breaks out over how to study cell death in cancer
By Philip Ward
VIENNA - When Dr. Uwe Haberkorn drew breath after his ECR presentation during a New Horizons session on imaging the hallmarks of cancer, he probably didn't anticipate the lively debate that was to follow.
March 8, 2014
2014 03 09 11 15 32 211 2014 03 08 Padhani 200
Hybrid imaging gathers momentum in cardiac indications
By Becky McCall
VIENNA - Hybrid imaging is gaining acceptance as opportunities using combinations of modalities emerge and promise to optimize cardiac imaging, according to expert speakers in today's session called "Hybrid cardiovascular imaging: Where should we go?" at ECR 2014.
March 5, 2014
2014 03 03 17 53 20 74 2014 03 06 Hybrid Cardiac Imaging 200
AAA gets orphan drug status, buys private distributor
By AuntMinnieEurope.com staff writers
Advanced Accelerator Applications (AAA) has received orphan drug designation status for gallium-68 DOTATATE.
March 4, 2014
Eckert & Ziegler opens Abstract Award competition
By AuntMinnieEurope.com staff writers
Eckert & Ziegler is again conducting its Abstract Award competition.
March 4, 2014
AAA gets orphan drug status
By AuntMinnieEurope.com staff writers
Advanced Accelerator Applications (AAA) has received orphan drug designation status for gallium-68 DOTATATE.
March 4, 2014
Ga-68 DOTATATE PET/CT detects neuroendocrine tumor recurrence
By Wayne Forrest
German researchers have confirmed the efficacy of PET/CT with the radiopharmaceutical gallium-68 (Ga-68) DOTATATE for detecting the recurrence of neuroendocrine tumors, in a study published in the February issue of Radiology.
February 26, 2014
2014 02 20 17 31 07 273 Pet Ct Net Haug Rad 450 20140221003342
Piramal gets approval from EC for NeuraCeq
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Piramal Imaging announced that its NeuraCeq radiotracer has received marketing authorization from the European Commission (EC).
February 25, 2014
Previous Page
Page 55 of 90
Next Page